Intrinsiqq
Phibro Animal Health Corporation logo

Phibro Animal Health Corporation Insider Trading

PAHC

⊜ Compare
Last 12 months

Insiders bought 318K and sold $12.7M on the open market.

All of the selling was scheduled in advance under 10b5-1 plans.

Net open-market
−$12.4M
1 buy · 14 sales
Under a 10b5-1 plan
100%
of the value sold
Insiders who bought / sold
1 / 1
executives and directors
Last open-market buy
May 2026
May 29, 2026

Get an email when PAHC's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • May 29
    E Thomas Corcoran
    Director · bought 10,000 at $31.77
    318K
    32% of stake
  • May 5 – 710b5-1 plan
    Jack Bendheim
    President and CEO · sold 18,608 at avg $54.62
    $1.02M
    20% of stake
  • Apr 28 – 3010b5-1 plan
    Jack Bendheim
    President and CEO · sold 21,120 at avg $53.86
    $1.14M
    19% of stake
  • Apr 21 – 2310b5-1 plan
    Jack Bendheim
    President and CEO · sold 21,120 at avg $54.79
    $1.16M
    16% of stake
  • Apr 14 – 1610b5-1 plan
    BFI Co., LLC
    Large holder · sold 21,120 at avg $56.89
    $1.2M
    14% of stake
  • Mar 30 – 3110b5-1 plan
    Jack Bendheim
    President and CEO · sold 14,080 at avg $53.75
    757K
    20% of stake
  • Mar 24 – 2610b5-1 plan
    Jack Bendheim
    President and CEO · sold 21,120 at avg $55.21
    $1.17M
    23% of stake
  • Mar 17 – 1910b5-1 plan
    Jack Bendheim
    President and CEO · sold 22,880 at avg $52.40
    $1.2M
    20% of stake
  • Mar 1310b5-1 plan
    Jack Bendheim
    President and CEO · sold 5,280 at $48.91
    258K
    4.5% of stake
  • Feb 24 – 2610b5-1 plan
    BFI Co., LLC
    Large holder · sold 21,120 at avg $52.27
    $1.1M
    54% of stake
  • Feb 19 – 2010b5-1 plan
    BFI Co., LLC
    Large holder · sold 14,080 at avg $50.84
    716K
    26% of stake
  • Feb 13 – 1810b5-1 plan
    BFI Co., LLC
    Large holder · sold 14,080 at avg $51.68
    728K
    21% of stake
  • Feb 10 – 1110b5-1 plan
    Jack Bendheim
    President and CEO · sold 72,198 at avg $51.77
    $3.74M
    52% of stake
  • Feb 510b5-1 plan
    BFI Co., LLC
    Large holder · sold 110,842 at avg $48.38
    $5.36M
    44% of stake
  • Feb 3 – 410b5-1 plan
    Jack Bendheim
    President and CEO · sold 13,180 at avg $41.39
    545K
    17% of stake
  • Jan 29 – 3010b5-1 plan
    BFI Co., LLC
    Large holder · sold 13,465 at avg $40.11
    540K
    22% of stake
  • Jan 2310b5-1 plan
    Jack Bendheim
    President and CEO · sold 1,235 at $40.55
    50K
    1.9% of stake
  • Jan 21 – 2210b5-1 plan
    Jack Bendheim
    President and CEO · sold 27,845 at avg $41.82
    $1.16M
    45% of stake
  • Jan 13 – 1510b5-1 plan
    BFI Co., LLC
    Large holder · sold 14,134 at avg $40.31
    570K
    19% of stake
  • Jan 910b5-1 plan
    BFI Co., LLC
    Large holder · sold 213 at $40.16
    9K
    0.4% of stake
  • Jan 710b5-1 plan
    Jack Bendheim
    President and CEO · sold 328 at $40.09
    13K
    0.6% of stake
  • Dec 11, 202510b5-1 plan
    BFI Co., LLC
    Large holder · sold 5,752 at avg $40.93
    235K
    9.3% of stake
  • Dec 8, 2025 – Dec 9, 202510b5-1 plan
    Jack Bendheim
    President and CEO · sold 4,808 at avg $40.09
    193K
    7.2% of stake
  • Dec 3, 2025 – Dec 4, 202510b5-1 plan
    BFI Co., LLC
    Large holder · sold 7,040 at avg $41.00
    289K
    9.6% of stake
  • Nov 28, 2025 – Dec 1, 202510b5-1 plan
    BFI Co., LLC
    Large holder · sold 7,040 at avg $42.10
    296K
    14% of stake
  • Nov 25, 2025 – Nov 26, 202510b5-1 plan
    BFI Co., LLC
    Large holder · sold 12,320 at avg $43.97
    542K
    20% of stake
  • Nov 20, 202510b5-1 plan
    BFI Co., LLC
    Large holder · sold 3,520 at avg $41.76
    147K
    5.3% of stake
  • Nov 17, 2025 – Nov 18, 202510b5-1 plan
    BFI Co., LLC
    Large holder · sold 10,560 at avg $44.19
    467K
    14% of stake
  • Nov 12, 2025 – Nov 13, 202510b5-1 plan
    BFI Co., LLC
    Large holder · sold 30,337 at avg $45.01
    $1.37M
    58% of stake
  • Nov 7, 2025 – Nov 10, 202510b5-1 plan
    BFI Co., LLC
    Large holder · sold 41,823 at avg $45.08
    $1.89M
    53% of stake
  • Nov 4, 2025 – Nov 5, 202510b5-1 plan
    Jack Bendheim
    President and CEO · sold 7,040 at avg $42.16
    297K
    8.2% of stake
  • Oct 28, 2025 – Oct 30, 202510b5-1 plan
    Jack Bendheim
    President and CEO · sold 10,560 at avg $41.43
    438K
    15% of stake
  • Oct 22, 2025 – Oct 24, 202510b5-1 plan
    BFI Co., LLC
    Large holder · sold 18,899 at avg $40.53
    766K
    21% of stake
  • Oct 17, 2025 – Oct 20, 202510b5-1 plan
    Jack Bendheim
    President and CEO · sold 16,775 at avg $40.37
    677K
    16% of stake
  • Sep 30, 202510b5-1 plan
    BFI Co., LLC
    Large holder · sold 20,664 at $40.38
    834K
    26% of stake
  • Sep 18, 202510b5-1 plan
    Jack Bendheim
    President and CEO · sold 7,022 at $40.26
    283K
    8.2% of stake
  • Sep 9, 2025 – Sep 11, 202510b5-1 plan
    Jack Bendheim
    President and CEO · sold 21,120 at avg $40.59
    857K
    28% of stake
  • Feb 24, 2025
    E Thomas Corcoran
    Director · bought 5,000 at $22.10
    111K
    20% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch PAHC, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with PAHC

CompareIntrinsic value
ALKSAlkermes plc
$45.90+0.46%36
INDVIndivior Pharmaceuticals, Inc.
$36.28+2.57%80
MDGLMadrigal Pharmaceuticals, Inc.
$400.67+1.10%10
ACADAcadia Pharmaceuticals Inc.
$21.49+4.47%74
INSMInsmed Inc.
$110.00+5.32%40
APLSApellis Pharmaceuticals, Inc.
$3.10+3.29%83
PBHPrestige Consumer Healthcare Inc.
$53.28+7.55%48
SRPTSarepta Therapeutics Inc.
$18.99+2.43%51

Held by ETFs

PAHC is in 61 US ETFs. The largest of them, with PAHC's weight in each:

Spot a number that looks wrong? Check it in PAHC's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing PAHC

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.